stockportfolio.pro
Stocks / ABBV vs CERT
ABBV vs CERT
AbbVie Inc. and Certara, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| AbbVie Inc. (ABBV) | Certara, Inc. (CERT) | |
|---|---|---|
| Market cap | $398.3B | $0.8B |
| Revenue (latest FY) | $61.16B | $418.84M |
| Net income (latest FY) | $4.23B | $-1.59M |
| Revenue growth (5y CAGR) | 6.0% | 11.5% |
| Net margin | 6.9% | -0.4% |
| Return on equity | -129.2% | -0.2% |
| P/E ratio | 111.0 | — |
| Dividend yield | 3.1% | — |
| Profitable years (of last 10) | 10 | 1 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ABBV — free Open CERT — freeFrequently asked questions
Which is bigger, ABBV or CERT?
AbbVie Inc. is larger by market capitalization — $398.3B versus $0.8B.
Which grows faster, ABBV or CERT?
Over the last five fiscal years, Certara, Inc. grew revenue faster — 11.5%/yr versus 6.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.